Case 550 · ICHD-3 8.2.1
8.2.1 Ergotamine-overuse headache
- Origin
- Synthetic
- Language
- English — also available in German
- Contributed by
- Imported case — HeadAI synthetic vignettes (de Andrade JBC, da Silva Costa TB, Vasconcelos JL, Lopes TLM, Balsells MD, Cristofolini VL, Querobin SO, Filho FMR. Validation of an AI-based platform for structured diagnosis of headache disorders using ICHD-3 criteria. BMC Neurology 25, 489 (2025). doi:10.1186/s12883-025-04473-1. Dataset: Andrade J. Head.AI Platform. Mendeley Data, V2 (2025). doi:10.17632/4fms6cw2s5.2)
Anamnesis
Identification: A 45-year-old female patient with a history of episodic migraine since adolescence reports a progressive worsening of headaches over the past 6 months. Current Illness History: She has been regularly using ergotamine tartrate (2 tablets/day) for at least 15 days per month over the past 3 months for symptomatic relief. She experiences daily or almost daily headaches (≥15 days/month) with variable characteristics (pulsatile/pressure), bilateral location, and moderate to severe intensity. The headaches worsen with ergotamine withdrawal and temporarily improve after taking a new dose. There are no other symptoms suggestive of secondary causes. Complementary Examinations: Neuroimaging (brain MRI) shows no abnormalities.
Report this case — e.g. suspected re-identification risk.